Drug Profile


Alternative Names: R 72063

Latest Information Update: 19 Dec 1996

Price : $50

At a glance

  • Originator Janssen L.P.
  • Class Antiepileptic drugs; Neuroprotectants; Small molecules; Triazoles
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 19 Dec 1996 New profile
  • 19 Dec 1996 Discontinued-II for Epilepsy in Belgium (PO)
  • 19 Dec 1996 Discontinued-II for Epilepsy in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top